[1] |
World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
|
[2] |
中华医学会结核病学分会. 非结核分枝杆菌病诊断与治疗指南(2020年版). 中华结核和呼吸杂志, 2020, 43(11):918-946. doi:10.3760/cma.j.cn112147-20200508-00570.
|
[3] |
李朝俊, 孙诚鸿, 金文宇. 非结核分枝杆菌肺病与耐多药肺结核的胸部CT征象对照分析. 临床荟萃, 2021, 36(6):530-534. doi:10.3969/j.issn.1004-583X.2021.06.010.
|
[4] |
Wittram C, Weisbrod GL. Mycobacterium avium complex lung disease in immunocompetent patients: radiography-CT correlation. Br J Radiol, 2002, 75(892):340-344. doi:10.1259/bjr.75.892.750340.
|
[5] |
Ma J, Zhou Z, Ren Y, et al. Computerized detection of lung nodules through radiomics. Med Phys, 2017, 44(8):4148-4158. doi:10.1002/mp.12331.
pmid: 28494110
|
[6] |
Coroller TP, Agrawal V, Huynh E, et al. Radiomic-Based Pathological Response Prediction from Primary Tumors and Lymph Nodes in NSCLC. J Thorac Oncol, 2017, 12(3):467-476. doi:10.1016/j.jtho.2016.11.2226.
pmid: 27903462
|
[7] |
Gopalaswamy R, Shanmugam S, Mondal R, et al. Of tuberculosis and non-tuberculous mycobacterial infections-a comparative analysis of epidemiology,diagnosis and treatment. J Biomed Sci, 2020, 27(1):74. doi:10.1186/s12929-020-00667-6.
pmid: 32552732
|
[8] |
Duan H, Han X, Wang Q, et al. Clinical Significance of Nontuberculous Mycobacteria Isolated From Respiratory Specimens in a Chinese Tuberculosis Tertiary Care Center. Sci Rep, 2016, 6:36299. doi:10.1038/srep36299.
pmid: 27808247
|
[9] |
Liu CF, Song YM, He WC, et al. Nontuberculous mycobacteria in China: incidence and antimicrobial resistance spectrum from a nationwide survey. Infect Dis Poverty, 2021, 10(1):59. doi:10.1186/s40249-021-00844-1.
|
[10] |
Jia H, Pan L, Wang G, et al. Assessment of Interferon-Gamma Release Assay in Patients with Non-Tuberculous Mycobacteria Pulmonary Disease. Clin Lab, 2019, 65(10):10.7754/Clin.Lab.2019.181247. doi:10.7754/Clin.Lab.2019.181247.
|
[11] |
洪创跃, 李金莉, 赵广录, 等. 2013—2017年深圳市非结核分枝杆菌流行状况分析. 中国防痨杂志, 2019, 41(5):529-533. doi:10.3969/j.issn.1000-6621.2019.05.011.
|
[12] |
Yang C, Luo X, Fan L, et al. Performance of Interferon-Gamma Release Assays in the Diagnosis of Nontuberculous Mycobacterial Diseases-A Retrospective Survey From 2011 to 2019. Front Cell Infect Microbiol, 2021, 10:571230. doi:10.3389/fcimb.2020.571230.
|
[13] |
Kang WL, Wang GR, Wu MY, et al. Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation. Chin Med J (Engl), 2018, 131(3):268-275. doi:10.4103/0366-6999.223860.
|
[14] |
Yan Q, Wang W, Zhao W, et al. Differentiating nontuberculous mycobacterium pulmonary disease from pulmonary tuberculosis through the analysis of the cavity features in CT images using radiomics. BMC Pulm Med, 2022, 22(1):4. doi:10.1186/s12890-021-01766-2.
pmid: 34991543
|
[15] |
谢智恩, 黎惠如, 宋敏, 等. 非结核分枝杆菌肺病、活动性肺结核以及耐多药肺结核的CT影像对比分析. 医学影像学杂志, 2020, 30(12):2224-2227.
|
[16] |
Ying C, Li X, Lv S, et al. T-SPOT with CT image analysis based on deep learning for early differential diagnosis of nontuberculous mycobacteria pulmonary disease and pulmonary tuberculosis. Int J Infect Dis, 2022, 125:42-50. doi:10.1016/j.ijid.2022.09.031.
|